CXCL8 and metabolic dysfunction-associated steatohepatitis: SIBO prevalence was higher in NASH (77.8%) vs. controls (31.3%). Only IL-8 was significantly elevated (p = 0.04) and correlated with TLR-4 expression (r = 0.51). No differences in LBP or other cytokines.